Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD
Clinical trial NCT02268396 · COMPLETED
Trial details
- NCT number
- NCT02268396
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-01-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.